Clemizole hydrochloride is anH1histamine receptorantagonist, is found to substantially inhibitHCVreplication. Clemizole hydrochloride is an inhibitor ofTRPC5 channel. TheIC₅₀of Clemizole hydrochloride for RNA binding byNS4Bis 24 nM, whereas itsEC₅₀for viral replication is 8 μM.

IC50: 24 nM (NS4B)^[1]
H1 histamine receptor^[1]

Clemizole hydrochloride is found to inhibit HCV RNA replication in cell culture that is mediated by its suppression of NS4B’s RNA binding, with little toxicity for the host cell. The EC₅₀of Clemizole on the W55R mutant J6/JFH RNA is ~18 μM (2.25 times the EC₅₀of the wild-type RNA)^[1]. Clemizole is a novel inhibitor of TRPC5 channels. Clemizole efficiently blocks TRPC5 currents and Ca²⁺entry in the low micromolar range (IC₅₀=1.0-1.3 μM). Clemizole exhibits a six-fold selectivity for TRPC5 over TRPC4β (IC₅₀=6.4 μM), the closest structural relative of TRPC5, and an almost 10-fold selectivity over TRPC3 (IC₅₀=9.1 μM) and TRPC6 (IC₅₀=11.3 μM). Clemizole hydrochloride as a novel blocker of TRPC5 with a half-maximal inhibitory concentration of 1.1 μM. The concentration-response curves confirmed a concentration-dependent block of TRPC5 by Clemizole and revealed an apparent IC₅₀of 1.1±0.04 μM^[2].

Clemizole hydrochloride has an unexpectedly short plasma half-life (measured at 0.15 hours); it is very rapidly biotransformed into a glucuronide (M14) and a dealkylated metabolite (M12) and into a variety of lesser metabolites in C57BL/6J mice^[3].

362.30

Solid

C₁₉H₂₁Cl₂N₃

1163-36-6

盐酸克立咪唑

Room temperature in continental US; may vary elsewhere.

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

DMSO : 33.33 mg/mL(92.00 mM;Need ultrasonic)

H₂O : 20 mg/mL(55.20 mM;Need ultrasonic)

请根据半岛bd体育手机客户端 在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的半岛bd体育手机客户端 失效。
储备液的保存方式和期限：-80℃, 6 months; -20℃, 1 month (sealed storage, away from moisture)。-80℃ 储存时，请在 6 个月内使用，-20℃ 储存时，请在 1 个月内使用。

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液，再依次添加助溶剂：

——为保证实验结果的可靠性，澄清的储备液可以根据储存条件，适当保存；体内实验的工作液，建议您现用现配，当天使用； 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比；如在配制过程中出现沉淀、析出现象，可以通过加热和/或超声的方式助溶

• 1.

  请依序添加每种溶剂： 5% DMSO40%PEG3005%Tween-8050% saline

  Solubility: ≥ 2.5 mg/mL (6.90 mM); Clear solution
• 2.

  请依序添加每种溶剂： 5% DMSO95% (20%SBE-β-CDin saline)

  Solubility: ≥ 2.5 mg/mL (6.90 mM); Clear solution
• 3.

  请依序添加每种溶剂： 10% DMSO40%PEG3005%Tween-8045% saline

  Solubility: ≥ 2.08 mg/mL (5.74 mM); Clear solution

  此方案可获得 ≥ 2.08 mg/mL (5.74 mM，饱和度未知) 的澄清溶液。

  以 1 mL 工作液为例，取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中，混合均匀；向上述体系中加入50 μL Tween-80，混合均匀；然后继续加入 450 μL生理盐水定容至 1 mL。

  将 0.9 g 氯化钠，完全溶解于 100 mL ddH2O 中，得到澄清透明的生理盐水溶液
• 4.

  请依序添加每种溶剂： 10% DMSO90% (20%SBE-β-CDin saline)

  Solubility: ≥ 2.08 mg/mL (5.74 mM); Clear solution

  此方案可获得 ≥ 2.08 mg/mL (5.74 mM，饱和度未知) 的澄清溶液。

  以 1 mL 工作液为例，取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL20% 的 SBE-β-CD 生理盐水水溶液中，混合均匀。

  将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中，再用生理盐水定容至 10 mL，完全溶解，澄清透明
• 5.

  请依序添加每种溶剂： 10% DMSO90%corn oil

  Solubility: ≥ 2.08 mg/mL (5.74 mM); Clear solution

  此方案可获得 ≥ 2.08 mg/mL (5.74 mM，饱和度未知) 的澄清溶液，此方案不适用于实验周期在半个月以上的实验。

  以 1 mL 工作液为例，取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中，混合均匀。

• 6.

  请依序添加每种溶剂： 1% DMSO99% saline

  Solubility: 0.5 mg/mL (1.38 mM); Clear solution; Need ultrasonic